Selecting antihypertensive therapy in the pregnant woman with diabetes mellitus

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 9, Issue 1, 2000, Pages 66-69

  Conway, Deborah L ^a   Langer, Oded ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Antihypertensive agents; Diabetic nephropathy; Hypertension; Pregnancy in diabetes

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BENZOTHIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; HYDRALAZINE; ISRADIPINE; LABETALOL; METHYLDOPA; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; PAPAVERINE DERIVATIVE; VERAPAMIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MATERNAL HYPERTENSION; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034025361     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Klein BEK, Klein R, Moss SE. Blood pressure in a population of diabetic persons diagnosed after 30 years of age. Am J Public Health 1984;74:336-339.
2. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 1996.
3. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257-265.
4. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2436.
5. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986;67:517-522.
6. Kincaid-Smith P, Bullen M, Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J 1966;1:274-276.
7. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990; 162:960-967.
8. Pickles CJ, Pipkin FB, Symonds EM. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol 1992;99:964-968.
9. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzales N, Guthrie G, Oberman A, Rutan GH, Stamler J. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-1892.
10. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997;20:S5-S13.
11. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998;352:213-219.
12. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
13. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-1155.
14. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effects of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
15. Rosa FW, Bosco LA, Graham CF, Milstein JB, Dreis M, Creamer J. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol 1989;74:371-374.
16. Barr M, Cohen MM. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 1991;44:485-495.
17. Harewood WJ, Phippard AF, Duggin GG, Horvath JS, Tiller DJ. Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas). Am J Obstet Gynecol 1994;171:633-642.
18. Pipkin FB, Symonds EM, Turner SR. The effect of captopril (SQ14225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol 1982;323:415-422.
19. Mastrobattista JM. Angiotensin converting enzyme inhibitors in pregnancy. Semin Perinatol 1997;21:124-134.
20. Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. Morb Mortal Wkly Rep 1997;46:240-242.
21. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-150.
22. Slataper R, Vicknair N, Sadler R, Bakris GL. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993;153:973-980.
23. O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomized, double-blind study. J Hum Hypertens 1993;7:333-339.
24. Ruggenenti P, Mosconi L, Bianchi L, Cortesi L, Campana M, Pagani G, Mecca G, Remuzz G. Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. Am J Kidney Dis 1994;24:753-761.
25. Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 113:987-988.
26. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM-associated nephropathy. Kidney Int 1996;50:1641-1650.
27. Guasch A, Parham M, Zayas CF, Campbell O, Nzerue C, Macon E. Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African-Americans with non-insulin-dependent diabetes mellitus and nephropathy. J Am Soc Nephrol 1997;8:793-798.
28. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998;338:645-652.
29. Poulter NR. Calcium antagonists and the diabetic patient: a response to recent controversies. Am J Cardiol 1998;82:40R-41R.
30. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, McElhatton PR, Schmidt MA, Koren G. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-828.
31. Belfort MA, Anthony J, Buccimazza A, Davey DA. Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension. Am J Obstet Gynecol 1990;75:970-974.